Endothelial dysfunction in hypertension

Journal of Hypertension, Supplement

Volumn 14, Issue 5, 1996, Pages

  Vanhoutte, Paul M ^a  

^a IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

Endoperoxides; Endothelium dependent contracting factor; Endothelium derived hyperpolarizing factor; Nitric oxide; Thromboxane A2

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOPEROXIDE; ENDOTHELIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE; PROSTACYCLIN; SUPEROXIDE; THROMBOXANE A2;

CONFERENCE PAPER; DRUG EFFICACY; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; HYPERTENSION; PRIORITY JOURNAL; SMOOTH MUSCLE TONE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; VASOCONSTRICTION; VASODILATION;

EID: 0030469192     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Furchgott RF, Zawadzki JV: The obligatory role of the endothelial cells In relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288:373-376.
2. Furchgott RF, Vanhoutte PM: Endothelium-derived relaxing and contracting factors. FASEB J 1989,3:2007-2018.
3. Vanhoutte PM: Endothelium and responsiveness of vascular smooth muscle. J Hypertens 1987,5 (suppl 5):S115-S120.
4. Vanhoutte PM: Endothelium and control of vascular function. Hypertension 1989,13:658-667.
5. Lüscher TF, Vanhoutte PM: The Endothelium: Modulator of Cardiovascular Function. Boca Raton, Florida: CRC Press, Inc.; 1990:1-228.